The evolution of clinical training pathways

The clinical research profession’s learning environment has changed dramatically – with a shift from less well specified training routes to new forms of development opportunities, for example the the Pharmaceutical Medicine Specialty Training run by the Faculty of Pharmaceutical Medicine (FPM). These new training paths are more flexible, practical and use modular approaches, developing the knowledge needed to practice modern clinical pharmacology and empowering medics to master different therapy areas. Trainees are prepared to work in the realities of a clinical career, research, or drug development. 

Dr Lorch has been personally involved in the development of these new types of clinical training. She is a member of the trailblazer group developing the MSc Apprenticeship for Clinical Pharmacology Scientists within the Clinical Pharmacology Skills Alliance alongside the BPS and ABPI. Ulrike has also inputted into the development of the new FPM PMST specialty training curriculum and assessment.

Benefiting our macro environment

All these changes to pharmacological development bring benefits to the sector and the UK in general. Investing in a specialised workforce is crucial to companies like Richmond Pharmacology. It enables us to conduct the most advanced trials, retaining and developing the skills that bring us an advantage in delivering ground-breaking early phase clinical research. 

Constant change within the science and research environment needs a flexible workforce. It is therefore important to build curricula that are tailored for future ways of working within the sector. 

Read Dr Lorch’s full article in PharmaTimes here

Latest news

Futureproofing early phase clinical research for the next generation of investigators.

March 20, 2023
Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.
Read more

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

January 19, 2023
Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research.
Read more

Events

13th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions

Sunday, June 4th to Tuesday June 6th 2023
Exchange research-based knowledge on drug-drug interactions (DDIs) among all interested stakeholders from pharmaceutical industry, regulatory authorities, academic and health care delivery backgrounds and perspectives.
View event